Target intelligence / Profile preview

Vesicular inhibitory amino acid transporter (SLC32A1)

Target
SLC32A1
Molecular classification
Transporter, solute carrier family (SLC family), amino acid/polyamine transporter family II
01

Overview

Vesicular inhibitory amino acid transporter (SLC32A1, also known as VGAT or VIAAT) is an integral synaptic vesicle membrane protein responsible for transporting the inhibitory neurotransmitters GABA and glycine from the cytoplasm into synaptic vesicles of GABAergic and glycinergic neurons, as well as some endocrine cells[1][2][5][7]. This accumulation enables their regulated, exocytosis-mediated release during inhibitory neurotransmission in the central nervous system. SLC32A1 is unique in its function: it exchanges cytosolic GABA or glycine for vesicular protons, utilizing the electrochemical gradient generated by a vesicular H+-ATPase, with additional chloride co-transport required for optimal function[2][4][5]. Pathogenic variants of SLC32A1 can impair GABA/glycine filling of synaptic vesicles, leading to severe neurodevelopmental disorders and epilepsy in humans[3]. The protein is a specific molecular marker for GABAergic neurons and a member of the amino acid/polyamine transporter family II within the broader SLC (solute carrier) superfamily[5]. Currently, it is not a direct target for clinically approved drugs.

Other names
VGATVIAAThVIAATvesicular GABA transportervesicular inhibitory amino acid transporterGABA and glycine transportersolute carrier family 32 member 1SLC32A1bA122O1.1DEE114GEFSP12
02

Mechanism of action

Vesicular uptake/antiport of GABA or glycine (from cytoplasm into synaptic vesicle) in exchange for protons; vesicular stoichiometry also involves chloride co-transport for GABA/glycine loading[2][4][5].

03

Biological functions

Vesicular transport of inhibitory neurotransmitters (GABA and glycine)synaptic vesicle loadingneurotransmission inhibition
04

Disease associations

Neurodevelopmental and epileptic encephalopathyepilepsyintellectual disabilitymovement disorderspotentially neuropsychiatric disease
05

Safety considerations

Complete knockout of SLC32A1 is lethal in mice before or at birth, reflecting an essential role in inhibitory neurotransmission and suggesting that inhibition or major dysfunction could cause severe CNS toxicity, seizures, or death.
06

Interacting drugs

There are currently no approved drugs directly targeting VGAT/SLC32A1. The molecule is experimentally functionally linked to agents affecting GABAergic and glycinergic neurotransmission, but no specific clinical inhibitors or activators are described in public pharmacology databases.
07

Biomarkers

SLC32A1/VGAT is an established biomarker for identifying GABAergic (and some glycinergic) neurons in CNS tissue studies and pathology.

Beyond the preview

Go deeper on Vesicular inhibitory amino acid transporter (SLC32A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vesicular inhibitory amino acid transporter (SLC32A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call